about
Facile synthesis of octahydrobenzo[h]isoquinolines: novel and highly potent D1 dopamine agonistsDopamine D1 receptor signaling: does GαQ-phospholipase C actually play a role?Behavioural responses to the selective D1-dopamine receptor agonist R-SK&F; 38393 and the selective D2-agonist RU 24213 in young compared with aged ratsDopamine autoreceptors and the effects of drugs on locomotion and dopamine synthesisEffects of the D1 Dopamine Receptor Agonist Dihydrexidine (DAR-0100A) on Working Memory in Schizotypal Personality DisorderSKF-83959 is not a highly-biased functionally selective D1 dopamine receptor ligand with activity at phospholipase CDefective dopamine-1 receptor adenylate cyclase coupling in the proximal convoluted tubule from the spontaneously hypertensive ratDisruption of aminergic signalling reveals novel compounds with distinct inhibitory effects on mosquito reproduction, locomotor function and survival.Differential effects of dopamine agonists upon stimulated limbic and striatal dopamine release: in vivo voltammetric data.Selective D-1 dopamine receptor agonist effects in hyperkinetic extrapyramidal disorders.Renal dopaminergic mechanisms and hypertension: a chronology of advances.Enhanced muscimol-induced behavioral responses after 6-OHDA lesions: relevance to susceptibility for self-mutilation behavior in neonatally lesioned rats.6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.Importance of D1 and D2 receptors in the dorsal caudate-putamen for the locomotor activity and stereotyped behaviors of preweanling rats.Arterial medial necrosis and hemorrhage induced in rats by intravenous infusion of fenoldopam mesylate, a dopaminergic vasodilator.Dopamine release and metabolism in the rat frontal cortex, nucleus accumbens, and striatum: a comparison of acute clozapine and haloperidol.GPCR functional selectivity has therapeutic impact.Binding of [3H]SCH23390 in rat brain: regional distribution and effects of assay conditions and GTP suggest interactions at a D1-like dopamine receptor.Novel Dopamine Therapeutics for Cognitive Deficits in Schizophrenia.Dopamine receptor subtype agonists and feeding behavior.The role of dopamine in epilepsy.Identification of dopamine "D3" and "D4" binding sites, labelled with [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, as high agonist affinity states of the D1 and D2 dopamine receptors, respectively.Dopamine receptor-mediated spinal antinociception in the normal and haloperidol pretreated rat: effects of sulpiride and SCH 23390.Effects of dopamine receptor agonists and antagonists in the rat nucleus acumbens [proceedings]Pharmacological evidence for the subclassification of central dopamine receptors in the rat.Failure of SKF 38393-A to relieve parkinsonian symptoms induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the marmoset.[3H]SCH 23390 binding to human putamen D-1 dopamine receptors: stereochemical and structure-affinity relationships among 1-phenyl-1H-3-benzazepine derivatives as a guide to D-1 receptor topography.SCH-23390 antagonism of a D-2 dopamine agonist depends upon catecholaminergic neurons.Vasomotor responses of cerebral arterioles in situ to putative dopamine receptor agonists.Interactions of drugs acting on central dopamine receptors and cholinoceptors on yawning responses in the rat induced by apomorphine, bromocriptine or physostigmine.Effects of dopamine D1 and D2 receptor agonists and antagonists on seizures induced by chemoconvulsants in mice.Dopamine stimulates [3H]phorbol 12,13-dibutyrate binding in cultured striatal cells.Effects of dopamine D1 and D2 receptor agonists and antagonists on basal and ethanol-modulated beta-endorphin secretion from hypothalamic neurons in primary cultures.Excitatory neuronal responses to dopamine in the cerebral cortex: involvement of D2 but not D1 dopamine receptors.The cellular mechanism of action of nimodipine (BAY e 9736), a new calcium antagonist [proceedings]Effects of selective D1 and D2 dopamine agonists on cockroach salivary gland acinar cells in vitro.Mu-opioid receptors mediate the inhibitory effect of opioids on dopamine-sensitive adenylate cyclase in primary cultures of rat neostriatal neurons.Inhibitory role of D-1 dopamine receptors for the jerks induced by B-HT 920 in rats.Modulation of in vivo dopamine release by D2 but not D1 receptor agonists and antagonists.Binding of [3H]SKF 38393 to dopamine D-1 receptors in rat striatum in vitro; estimation of receptor molecular size by radiation inactivation.
P2860
Q24605720-49D71EB4-573F-40F9-A59B-F56FB612FC1FQ26864383-C5DE8FB0-963D-446C-BD64-68FD1CD172A2Q28360096-B290A841-E086-4E5F-A8A2-234A4EB605DDQ28362550-4324F75A-3592-4DF6-BC52-5ACC4ED654C2Q29038503-A9C47E03-9790-4D1D-8701-BAC28AA0B63FQ30400003-A47378B7-1E0D-457A-B887-95204EE942C8Q30449828-8C6D0CCF-A637-42E9-A08E-3C52691C225EQ30582295-D9FEB1C1-C3E1-4CAC-9FAC-0B3AE951FA9BQ31043351-9D45809F-D945-403F-9E87-A03F6051DCEFQ33628911-CE4A8167-B4CC-410F-978A-A990A9FC09BAQ33914046-3A9947A3-C571-404D-B038-814EB2844CD3Q33914211-B13AB982-2B8B-4AF8-AA57-37F8E00088CCQ34460119-22E5B8FA-0EFB-4B3F-80DE-A05194D8E8C0Q34958318-04F13871-5569-4A6E-887B-1922119758BEQ35835554-9CD81996-8F02-4415-BA99-E1A11D65E0FBQ35872139-E57C08C4-6611-4E45-8759-95EF167EAA99Q36880909-8536395C-9123-4E12-8254-901BF4D8C8F3Q38712373-6769613F-7279-4316-81AD-518E61B56D16Q38762256-9591188E-1E76-426B-B9FC-CD8F2C6EAE41Q41026217-4F601D42-4237-4471-81CF-D554F5203D90Q41095940-F4F45ECA-3D5D-474B-B45A-7A140132A5E4Q41353083-859AB895-0461-4956-84B1-D5E69E8DF4AEQ41828777-1DCDAE94-64D0-4BC2-B9BF-B7BCF0D48E15Q41834303-376A61F5-95A5-42FC-952A-1230ABC28A3BQ41943784-2A7D7CB5-9FC5-4E5D-9C30-6CD4419783B7Q42019268-D021B407-E5E5-433A-B2E2-D12222356668Q42203861-27ACB38F-364C-4AFE-A351-9080029584C7Q42220753-C14A7278-4CD7-4FD4-9134-61CD12D090C2Q42257457-B22E6194-9AC9-4772-A051-13A3AA1DA237Q42275054-ED953AA5-6F76-4BC5-A5A7-97637ECAF777Q42284572-E908A936-639E-47D5-89FA-5BBF07CD6D9EQ42450855-CF3F960E-A8C7-40CC-B596-1DEA7E7A3F3EQ42521351-20AC19FB-E5C3-42A3-A8BC-578C6537524FQ42574272-65D96173-6649-4144-AC83-8A698407E6A8Q42631406-5239F548-A1F5-4A51-9358-1124A78A2817Q42709377-C724E0F6-4EBF-4DDA-97E7-5E65F4A5A22DQ43921855-BF9566CA-3FD8-46AB-A0D6-7BE7246B3813Q44582097-01BF3A10-7FD0-4496-B55D-A0051413092DQ46677579-2C8C7D34-AF37-4AC8-8841-6D66452FEDD0Q47199242-3162914B-A85B-4C81-B46F-00ABA41C6007
P2860
description
1978 nî lūn-bûn
@nan
1978年の論文
@ja
1978年学术文章
@wuu
1978年学术文章
@zh-cn
1978年学术文章
@zh-hans
1978年学术文章
@zh-my
1978年学术文章
@zh-sg
1978年學術文章
@yue
1978年學術文章
@zh
1978年學術文章
@zh-hant
name
The central effects of a novel dopamine agonist.
@en
The central effects of a novel dopamine agonist.
@nl
type
label
The central effects of a novel dopamine agonist.
@en
The central effects of a novel dopamine agonist.
@nl
prefLabel
The central effects of a novel dopamine agonist.
@en
The central effects of a novel dopamine agonist.
@nl
P2093
P1476
The central effects of a novel dopamine agonist.
@en
P2093
P304
P356
10.1016/0014-2999(78)90148-6
P407
P577
1978-08-01T00:00:00Z